About NephroPlus
NephroPlus is a company based in Hyderabad (India) founded in 2009 by Pullaiah Vuppala, Vikram Vuppala, and Kamal D Shah.. NephroPlus has raised $205.37 million across 13 funding rounds from investors including Bessemer Venture Partners, International Finance Corporation and Asian Development Bank. The company has 1,707 employees as of February 21, 2025. NephroPlus has completed 3 acquisitions, including DaVita India, Royal Care Dialysis Center and royalcaredialysis.com. NephroPlus offers products and services including In-Clinic Dialysis, Dialysis on Call, Home Hemodialysis, Holiday Dialysis, and Dialysis on Wheels. NephroPlus operates in a competitive market with competitors including DCDC, Apex Kidney Care, VitusCare, The Renal Project and Sparsh Nephrocare, among others.
- Headquarter Hyderabad, India
- Employees 1707 as on 21 Feb, 2025
- Founders Pullaiah Vuppala, Vikram Vuppala, Kamal D Shah
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Nephrocare Health Services Limited
-
Annual Revenue
$39.58 M (USD)12.64as on Mar 31, 2022
-
Net Profit
$-2.58 M (USD)-3585.11as on Mar 31, 2022
-
EBITDA
$1.95 M (USD)-56.88as on Mar 31, 2022
-
Total Equity Funding
$205.37 M (USD)
in 13 rounds
-
Latest Funding Round
$103 M (USD), Series F
May 03, 2024
-
Investors
Bessemer Venture Partners
& 24 more
-
Employee Count
1707
as on Feb 21, 2025
-
Investments & Acquisitions
DaVita India
& 2 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of NephroPlus
NephroPlus is a publicly listed company on the NSE with ticker symbol NEPHROPLUS in India, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of NephroPlus
NephroPlus offers a comprehensive portfolio of products and services, including In-Clinic Dialysis, Dialysis on Call, Home Hemodialysis, Holiday Dialysis, and Dialysis on Wheels. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides safe dialysis in clinical settings for kidney patients.
Offers convenient, on-demand dialysis at any location.
Delivers dialysis care directly in patients' homes.
Supports dialysis during travel at various destinations.
Provides mobile dialysis for easy access anywhere.
Unlock access to complete
Unlock access to complete
Funding Insights of NephroPlus
NephroPlus has successfully raised a total of $205.37M across 13 strategic funding rounds. The most recent funding activity was a Series F round of $103 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 13
- Last Round Series F — $103.0M
-
First Round
First Round
(30 Aug 2010)
- Investors Count 25
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2024 | Amount | Series F - NephroPlus | Valuation | Quadria Capital | |
| Jan, 2023 | Amount | Debt – Conventional - NephroPlus | Valuation |
investors |
|
| Dec, 2021 | Amount | Series E - NephroPlus | Valuation | 360 One |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in NephroPlus
NephroPlus has secured backing from 25 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Bessemer Venture Partners, International Finance Corporation and Asian Development Bank. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare private equity investments focused on Asian markets.
|
Founded Year | Domain | Location | |
|
Private equity, real estate, and credit investments are managed globally.
|
Founded Year | Domain | Location | |
|
Venture capital investments and support for entrepreneurs in technology and innovation sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by NephroPlus
NephroPlus has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include DaVita India, Royal Care Dialysis Center and royalcaredialysis.com. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Dialysis services are offered in Talisay, Philippines.
|
2019 | ||||
|
Chain of dialysis clinics
|
2013 | ||||
|
Provider of online medication information and resources. It offers detailed information on various medications, including uses, prices, composition, side effects, and dosages. The platform aims to empower individuals to make informed healthcare decisions by providing accessible and accurate medical details. It serves patients, caregivers, and healthcare professionals, supporting their health choices with reliable and concise information. The platform includes editorial and fact-checking policies to ensure accuracy and completeness.
|
2009 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - NephroPlus
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Nephroplus Comparisons
Competitors of NephroPlus
NephroPlus operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DCDC, Apex Kidney Care, VitusCare, The Renal Project and Sparsh Nephrocare, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Chain of dialysis and kidney clinics
|
|
| domain | founded_year | HQ Location |
Chain of dialysis clinics
|
|
| domain | founded_year | HQ Location |
Chain of dialysis clinics
|
|
| domain | founded_year | HQ Location |
Chain of dialysis clinics
|
|
| domain | founded_year | HQ Location |
Chain of dialysis clinics
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Nephroplus
Frequently Asked Questions about NephroPlus
When was NephroPlus founded?
NephroPlus was founded in 2009 and raised its 1st funding round 1 year after it was founded.
Where is NephroPlus located?
NephroPlus is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Who is the current CEO of NephroPlus?
Rohit Singh is the current CEO of NephroPlus.
Is NephroPlus a funded company?
NephroPlus is a funded company, having raised a total of $205.37M across 13 funding rounds to date. The company's 1st funding round was a Series E of $25M, raised on Aug 30, 2010.
How many employees does NephroPlus have?
As of Feb 21, 2025, the latest employee count at NephroPlus is 1,707.
What is the annual revenue of NephroPlus?
Annual revenue of NephroPlus is $39.58M as on Mar 31, 2022.
What does NephroPlus do?
NephroPlus was founded in 2009 in Hyderabad, India, as a provider in the healthcare sector focused on dialysis. Services are delivered through in-clinic, at-home, and mobile formats to support patients with kidney disease. A training academy is maintained for dialysis technicians and nurses. Educational resources and support programs are extended to enhance patient management of chronic conditions. Operations are centered in India with an emphasis on clinical standards.
Who are the top competitors of NephroPlus?
NephroPlus's top competitors include DCDC, Apex Kidney Care and VitusCare.
What products or services does NephroPlus offer?
NephroPlus offers In-Clinic Dialysis, Dialysis on Call, Home Hemodialysis, Holiday Dialysis, and Dialysis on Wheels.
Is NephroPlus publicly traded?
Yes, NephroPlus is publicly traded on NSE under the ticker symbol NEPHROPLUS.
How many acquisitions has NephroPlus made?
NephroPlus has made 3 acquisitions, including DaVita India, Royal Care Dialysis Center, and royalcaredialysis.com.
Who are NephroPlus's investors?
NephroPlus has 25 investors. Key investors include Bessemer Venture Partners, International Finance Corporation, Asian Development Bank, 360 One, and Quadria Capital.
What is NephroPlus's ticker symbol?
The ticker symbol of NephroPlus is NEPHROPLUS on NSE.
What is NephroPlus's valuation?
The valuation of NephroPlus is $236.37M as of Dec 2021.